Skip to main content
ST PHARM CO., LTD. logo

ST PHARM CO., LTD. — Investor Relations & Filings

Ticker · 237690 ISIN · KR7237690003 KO Manufacturing
Filings indexed 399 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 237690

About ST PHARM CO., LTD.

https://www.stpharm.co.kr/en

ST PHARM CO., LTD. is a global Contract Development and Manufacturing Organization (CDMO) specializing in Active Pharmaceutical Ingredients (APIs). The company provides technology-driven manufacturing services for gene therapies, with core expertise in oligonucleotides and various forms of RNA (xRNA), including messenger RNA (mRNA). In addition to nucleic acid-based medicines, ST Pharm offers custom manufacturing for small molecule APIs. The company's services operate under cGMP (current Good Manufacturing Practice) standards, providing comprehensive solutions that support the entire drug development lifecycle, from research and development to commercial-scale production for its global pharmaceutical partners.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서 (제19기 1분기)” covering the period January 1, 2026 to March 31, 2026 and contains detailed financial statements, capital changes, business overview, segment revenues and other substantive data. It is a full interim/quarterly report rather than a brief earnings release or mere announcement. Therefore, it should be classified as an Interim / Quarterly Report (IR). Q1 2026
2026-05-15 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 80% confidence The document is a notice of an upcoming corporate investor relations presentation (IR) event. It does not contain actual financial data or presentation slides, but simply announces the timing, venue, participants, and links. This fits the fallback category for general regulatory announcements (RNS) rather than an actual report or presentation material.
2026-05-14 Korean
주식등의대량보유상황보고서(일반)
Regulatory Filings
2026-04-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2026-04-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2026-04-30 Korean
기업설명회(IR)개최
Investor Presentation Classification · 85% confidence The document is an announcement of a corporate investor relations (IR) briefing, detailing date, time, venue, attendees, agenda (Q1 results review, global trends), and IR material posting. This clearly aligns with an Investor Presentation (IP) rather than a regulatory report or earnings release.
2026-04-27 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.